Arecoline induces epithelial mesenchymal transition in HK2 cells by upregulating the ERK‐mediated signaling pathway

Arecoline, a component of betel nuts, is a known carcinogen that causes oral cancers among those who chew betel nuts. Betel nut chewing is also associated with an increased risk of chronic kidney disease (CKD), but the role of arecoline in this association is unclear. This in vitro study investigate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Environmental toxicology 2020-09, Vol.35 (9), p.1007-1014
Hauptverfasser: Hsieh, Yi‐Hsien, Syu, Ru‐Jiang, Lee, Chu‐Che, Lin, Shin‐Huey, Lee, Chien‐Hsing, Cheng, Chun‐Wen, Tsai, Jen‐Pi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Arecoline, a component of betel nuts, is a known carcinogen that causes oral cancers among those who chew betel nuts. Betel nut chewing is also associated with an increased risk of chronic kidney disease (CKD), but the role of arecoline in this association is unclear. This in vitro study investigates the effects of arecoline on cultured human kidney (HK2) cells. We observed that arecoline had no effect on cell viability but increased cell migration in a dose‐dependent manner. Western blot analysis showed that arecoline treatment caused a dose‐dependent decrease in E‐cadherin expression and dose‐dependent increases in N‐cadherin, vimentin, α‐SMA, and collagen expression; reverse transcriptase‐polymerase chain reaction analysis revealed dose‐dependent increases in α‐SMA and collagen mRNA. Arecoline treatment upregulated the expression of phosphorylated extracellular signal‐regulated kinase through epithelial mesenchymal transition and renal fibrosis in HK2 cells. These findings demonstrate that arecoline plays a role in inducing the epithelial mesenchymal transition and fibrogenesis in renal tubule cells and suggest that arecoline promotes the progression of CKD.
ISSN:1520-4081
1522-7278
DOI:10.1002/tox.22937